Serum <i>N</i>‐Glycome analysis reveals pancreatic cancer disease signatures
Gerda C. M. Vreeker(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), R.G. Hanna-Sawires(Leiden University Medical Center), Viktoria Dotz(Human Vaccines Project Europe), Bert A. Bonsing(Leiden University Medical Center), Manfred Wuhrer(Leiden University Medical Center), Marco R. Bladergroen(Leiden University Medical Center), Yassene Mohammed(Leiden University Medical Center), Wilma E. Mesker(Leiden University Medical Center), Yuri E. M. van der Burgt(Leiden University Medical Center), Jan Nouta(Leiden University Medical Center), Simone Nicolardi(Leiden University Medical Center)
Cited by 42
Related Papers
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains
|Nature Genetics|2011|695
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer
|British journal of surgery|2004|665
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
|Genome Research|2011|610